Epigenetics와 정신장애
Epigenetics and Psychiatric Disorders
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
In the post-genomic era, the mechanisms controlling activation of genes are thought to be more important. Gene-environment interactions are crucial in both development and treatment of psychiatric disorders as they are complex genetic disorders. Epigenetics is defined as a change of gene expression that occurs without a change of DNA sequence and can be heritable by certain mechanisms. Epigenetic changes play essential roles in control of gene activation. DNA methylation, chromatin remodeling and RNAi act as key mechanisms for epigenetic modifications of genes. Here, we review the basic mechanisms of epigenetics and discuss their potential involvement of human diseases, including psychiatric disorders.
Abstract
In the post-genomic era, the mechanisms controlling activation of genes are thought to be more important. Gene-environment interactions are crucial in both development and treatment of psychiatric disorders as they are complex genetic disorders. Epigenetics is defined as a change of gene expression that occurs without a change of DNA sequence and can be heritable by certain mechanisms. Epigenetic changes play essential roles in control of gene activation. DNA methylation, chromatin remodeling and RNAi act as key mechanisms for epigenetic modifications of genes. Here, we review the basic mechanisms of epigenetics and discuss their potential involvement of human diseases, including psychiatric disorders.
참고문헌 (63)
- Ridley M, "Prologue: twelve hairy men. Nature via nurture: genes, experience, and what makes us human", HarperCollins, pp.1~6 (2003)
- Van Speybroeck L., "From epigenesis to epigenetics: the case of C. H. Waddington", Ann N Y Acad Sci, 981, pp.61~81 (2002)
- Wolffe AP., "Epigenetics: regulation through repression", Science, 286, pp.481~486 (1999)
- Rodenhiser D., "Epigenetics and human disease: translating basic biology into clinical applications", CMAJ, 174, pp.341~348 (2006)
- Keller EF., "The meaning of the gene function: What does a gene do? The century of the gene", pp.45~72 (2002), Harvard University Press
- Qiu J., "Epigenetics: unfinished symphony", Nature, 441, pp.143~145 (2006)
- Chang DK., "Cancer epigenetics", Korean J Gastroenterol, 44, pp.1~12 (2004)
- Lee BD., "The present status and future directions of molecular genetics studies on schizophrenia", J Korean Soc Biol Ther Psychiatry, 11(11) (2005)
- Quina AS., "Chromatin structure and epigenetics", Biochem Pharmacol, 72, pp.1563~1569 (2006)
- Arney KL., "Epigenetic aspects of differentiation", J Cell Sci, 117, pp.4355~4363 (2004)
- Bird AP., "Methylation-induced repression--belts, braces, and chromatin", Cell, 99, pp.451~454 (1999)
- Takai D., "Comprehensive analysis of CpG islands in human chromosomes 21 and 22", Proc Natl Acad Sci U S A, 99, pp.3740~3745 (2002)
- Nakao M., "Epigenetics: interaction of DNA methylation and chromatin", Gene, 278, pp.25~31 (2001)
- Lachner M., "The many faces of histone lysine methylation", Curr Opin Cell Biol, 14, pp.286~298 (2002)
- Narlikar GJ., "Cooperation between complexes that regulate chromatin structure and transcription", Cell, 108, pp.475~487 (2002)
- Bannister AJ., "Histone methylation: dynamic or static?", Cell, 109, pp.801~806 (2002)
- Shi Y., "Histone demethylation mediated by the nuclear amine oxidase homolog LSD1", Cell, 119, pp.941~953 (2004)
- Felsenfeld G., "Controlling the double helix", Nature, 421, pp.448~453 (2003)
- Hake SB., "Linking the epigenetic 'language' of covalent histone modifications to cancer", Br J Cancer, 96(l), pp.31~39 (2007)
- Razin A., "CpG methylation, chromatin structure and gene silencing-a three-way connection", EMBO J, 17, pp.4905~4908 (1998)
- Colvis CM., "Epigenetic mechanisms and gene networks in the nervous system", J Neurosci, 25, pp.10379~10389 (2005)
- Meaney MJ., "Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations", Annu Rev Neurosci, 24, pp.1161~1192 (2001)
- Champagne FA., "Variations in maternal care in the rat as a mediating influence for the effects of environment on development", Physiol Behav, 79, pp.359~371 (2003)
- Liu D., "Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress", Science, 277, pp.1659~1662 (1997)
- Detich N., "The methyl donor S-Adenosylmethionine inhibits active demethylation of DNA: a candidate novel mechanism for the pharmacological effects of S-Adenosylmethionine", J Biol Chem, 278, pp.20812~20820 (2003)
- Kloc A., "RNA interference guides histone modification during the S phase of chromosomal replication", Curr Biol, 18, pp.490~495 (2008)
- Downward J., "RNA interference", BMJ, 328, pp.1245~1248 (2004)
- Carrington JC., "Role of microRNAs in plant and animal development", Science, 301, pp.336~338 (2003)
- Morgan HD., "Epigenetic reprogramming in mammals", Hum Mol Genet, 14(1), pp.47~58 (2005)
- Verona RI., "Genomic imprinting: intricacies of epigenetic regulation in clusters", Annu Rev Cell Dev Biol, 19, pp.237~259 (2003)
- Nicholls RD., "Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes", Annu Rev Genomics Hum Genet, 2, pp.153~175 (2001)
- Weksberg R., "Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development", Hum Mol Genet, 12(1), pp.61~68 (2003)
- Kuno N., "Mature ovarian cystic teratoma with a highly differentiated homunculus: a case report", Birth Defects Res A Clin Mol Teratol, 70, pp.40~46 (2004)
- Devriendt K., "Hydatidiform mole and triploidy: the role of genomic imprinting in placental development", Hum Reprod Update, 11, pp.137~142 (2005)
- Gaudet F., "Induction of tumors in mice by genomic hypomethylation", Science, 300, pp.489~492 (2003)
- Cottrell SE., "Molecular diagnostic applications of DNA methylation technology", Clin Biochem, 37, pp.595~604 (2004)
- Esteller M., "A gene hypermethylation profile of human cancer", Cancer Res, 61, pp.3225~3229 (2001)
- Ye L., "Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids", J Endocrinol, 185, pp.337~343 (2005)
- Fitzpatrick DR., "Methylation and demethylation in the regulation of genes, cells, and responses in the immune system", Clin Immunol, 109, pp.37~45 (2003)
- Oelke K., "Decreased T cell ERK pathway signaling may contribute to the development of lupus through effects on DNA methylation and gene expression", Int Rev Immunol, 23, pp.315~331 (2004)
- King RA., "The genetic basis of common diseases. 2nd ed" (2002), Oxford university press
- Petronis A., "Human morbid genetics revisited: relevance of epigenetics", Trends Genet, 17, pp.142~146 (2001)
- Lee YS., "An overview of schizophrenia genetics in the post-genomic era", pp.17~39 (2002), Yong-in Psychiatry Bull
- Tsankova N., "Epigenetic regulation in psychiatric disorders", Nat Rev Neurosci, 8, pp.355~367 (2007)
- Li J., "Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling", J Neurochem, 90, pp.1117~1131 (2004)
- Brami-Cherrier K., "Parsing molecular and behavioral effects of cocaine in mitogen- and stress-activated protein kinase-1-deficient mice", J Neurosci, 25, pp.11444~11454 (2005)
- Gregoire S., "Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation", J Biol Chem, 281, pp.4423~4433 (2006)
- Impagnatiello F., "A decrease of reelin expression as a putative vulnerability factor in schizophrenia", Proc Natl Acad Sci U S A, 95, pp.15718~15723 (1998)
- Chen Y., "On the epigenetic regulation of the human reelin promoter", Nucleic Acids Res, 30, pp.2930~2939 (2002)
- Tremolizzo L., "An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability", Proc Natl Acad Sci U S A, 99, pp.17095~17100 (2002)
- Dong E., "Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia", Proc Natl Acad Sci U S A, 102, pp.12578~12583 (2005)
- Phiel CJ., "Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen", J Biol Chem, 276, pp.36734~36741 (2001)
- Martinowich K., "New insights into BDNF function in depression and anxiety", Nat Neurosci, 10, pp.1089~1093 (2007)
- Duman RS., "A neurotrophic model for stress-related mood disorders", Biol Psychiatry, 59, pp.1116~1127 (2006)
- Tsankova NM., "Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures", J Neurosci, 24, pp.5603~5610 (2004)
- Lee MG., "Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications", Chem Biol, 13, pp.563~567 (2006)
- Tsankova NM., "Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action", Nat Neurosci, 9, pp.519~525 (2006)
- Everitt BJ., "Neural systems of reinforcement for drug addiction: from actions to habits to compulsion", Nat Neurosci, 8, pp.1481~1489 (2005)
- Kumar A., "Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum", Neuron, 48, pp.303~314 (2005)
- Li J., "Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling", J Neurochem, 90, pp.1117~1131 (2004)
- Schroeder FA., "Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse", Biol Psychiatry, 62, pp.55~64 (2007)
- Kamiya A., "A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development", Nat Cell Biol, 7, pp.1167~1178 (2005)
- Cohen-Bendahan CC., "Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings", Neurosci Biobehav Rev, 29, pp.353~384 (2005)
